CAM
TMO icon

Congress Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Congress Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Sell
8,475
-191,813
-96% -$92.1M 0.03% 257
2026
Q1 		$98.4M Sell
200,288
-8,690
-4% -$4.72M 0.71% 44
2025
Q4 		$121M Buy
208,978
+59,093
+39% +$33.4M 0.85% 33
2025
Q3 		$72.7M Sell
149,885
-12,613
-8% -$5.87M 0.48% 76
2025
Q2 		$65.9M Sell
162,498
-5,251
-3% -$2.2M 0.45% 89
2025
Q1 		$83.5M Buy
167,749
+31,894
+23% +$17.3M 0.62% 60
2024
Q4 		$70.7M Sell
135,855
-41,837
-24% -$23M 0.48% 84
2024
Q3 		$110M Buy
177,692
+156,631
+744% +$92.7M 0.75% 61
2024
Q2 		$11.6M Sell
21,061
-189
-0.9% -$108K 0.08% 174
2024
Q1 		$12.4M Buy
21,250
+1,155
+6% +$648K 0.09% 163
2023
Q4 		$10.7M Buy
20,095
+3,343
+20% +$1.62M 0.08% 173
2023
Q3 		$8.48M Buy
16,752
+973
+6% +$518K 0.08% 173
2023
Q2 		$8.23M Sell
15,779
-1,294
-8% -$698K 0.07% 183
2023
Q1 		$9.84M Buy
17,073
+1,072
+7% +$604K 0.09% 165
2022
Q4 		$8.81M Buy
16,001
+9,848
+160% +$5.22M 0.09% 164
2022
Q3 		$3.12M Sell
6,153
-883
-13% -$494K 0.03% 236
2022
Q2 		$3.82M Sell
7,036
-1,049
-13% -$577K 0.04% 238
2022
Q1 		$4.78M Sell
8,085
-188,206
-96% -$108M 0.04% 234
2021
Q4 		$131M Sell
196,291
-41,581
-17% -$26M 1% 44
2021
Q3 		$136M Buy
237,872
+17,389
+8% +$9.54M 1.06% 36
2021
Q2 		$111M Buy
220,483
+2,184
+1% +$1.03M 0.93% 52
2021
Q1 		$99.6M Sell
218,299
-884
-0.4% -$422K 0.9% 56
2020
Q4 		$102M Sell
219,183
-6,565
-3% -$3.08M 0.96% 51
2020
Q3 		$99.7M Sell
225,748
-3,875
-2% -$1.6M 1.08% 38
2020
Q2 		$83.2M Buy
229,623
+1,335
+0.6% +$447K 0.99% 51
2020
Q1 		$64.7M Sell
228,288
-4,553
-2% -$1.44M 0.99% 54
2019
Q4 		$75.6M Sell
232,841
-6,235
-3% -$1.89M 0.92% 58
2019
Q3 		$69.6M Sell
239,076
-4,150
-2% -$1.19M 0.9% 57
2019
Q2 		$71.4M Sell
243,226
-2,040
-0.8% -$562K 0.91% 55
2019
Q1 		$67.1M Sell
245,266
-8,005
-3% -$1.99M 0.88% 56
2018
Q4 		$56.7M Sell
253,271
-3,032
-1% -$711K 0.85% 58
2018
Q3 		$62.6M Buy
256,303
+2,909
+1% +$669K 0.81% 58
2018
Q2 		$52.5M Sell
253,394
-4,548
-2% -$965K 0.72% 67
2018
Q1 		$53.3M Sell
257,942
-10,577
-4% -$2.22M 0.75% 68
2017
Q4 		$51M Sell
268,519
-5,603
-2% -$1.07M 0.74% 70
2017
Q3 		$51.9M Sell
274,122
-8,620
-3% -$1.56M 0.8% 64
2017
Q2 		$49.3M Sell
282,742
-10,993
-4% -$1.85M 0.88% 59
2017
Q1 		$45.1M Sell
293,735
-10,141
-3% -$1.55M 0.86% 68
2016
Q4 		$42.9M Sell
303,876
-21,546
-7% -$3.18M 0.9% 69
2016
Q3 		$51.8M Sell
325,422
-10,122
-3% -$1.56M 1.14% 33
2016
Q2 		$49.6M Sell
335,544
-6,175
-2% -$911K 1.14% 33
2016
Q1 		$48.4M Buy
341,719
+450
+0.1% +$60.3K 1.17% 32
2015
Q4 		$48.4M Buy
+341,269
New +$45.5M 1.2% 31
2015
Q3 		– Sell
-1,602
Closed -$208K – 228
2015
Q2 		$208K Sell
1,602
-402
-20% -$52.4K 0.01% 221
2015
Q1 		$269K Buy
2,004
+4
+0.2% +$516 0.01% 209
2014
Q4 		$251K Hold
2,000
– – 0.01% 219
2014
Q3 		$243K Hold
2,000
– – 0.01% 221
2014
Q2 		$236K Hold
2,000
– – 0.01% 225
2014
Q1 		$240K Hold
2,000
– – 0.01% 228
2013
Q4 		$223K Buy
+2,000
New +$199K 0.01% 218

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Congress Asset Management's TMO Position: Q2 2026 in Review

Congress Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 96% in Q2 2026, selling an estimated $92.1M and leaving 8,475 shares worth $4.25M. The position accounts for 0.03% of the portfolio, ranked #257.

Congress Asset Management first reported a position in TMO in Q4 2013 and has held it in 50 quarters since. The position peaked at $136M in Q3 2021. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Congress Asset Management held 8,475 shares of Thermo Fisher Scientific worth $4.25M as of Q2 2026.
  • Congress Asset Management sold 191,813 Thermo Fisher Scientific shares in Q2 2026, an estimated $92.1M.
  • Thermo Fisher Scientific made up 0.03% of Congress Asset Management's portfolio in Q2 2026, its #257 holding.
  • Congress Asset Management first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 50 quarters since.
  • Congress Asset Management's Thermo Fisher Scientific position peaked at $136M in Q3 2021.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.